Lidia Palenciano Castro

Ms. Lidia Palenciano Castro

I3M - CSIC
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2022 in Quantum Beam Science
Verified
Journal Article
Open access
PDF file
ATAlberto Torralba
Alberto Torralba
Lidia Palenciano CastroLidia Palenciano Castro
Lidia Palenciano Castro
AVAlicia Reija Vecino
Alicia Reija Vecino
JRJuan Pablo Rigla
Juan Pablo Rigla
JPJuan Peñas
Juan Peñas
MSMichael Seimetz
Michael Seimetz
Laser–plasma proton sources and their applications to preclinical research has become a very active field of research in recent years. In addition to their small dimensions as compared to classical ion accelerators, they offer the possibility to study the biological effects of ultra-short particle bunches and the correspondingly high dose rates. We report on the design of an experimental setup for the irradiation of cell cultures at the L2A2 laboratory at the University of Santiago de Compostela, making use of a 1.2 J Ti: Sapphire laser with a 10 Hz repetition rate. Our setup comprises a proton energy separator consisting of two antiparallel magnetic fields realized by a set of permanent magnets. It allows for selecting a narrow energy window around an adaptable design value of 5 MeV out of the initially broad spectrum typical for Target Normal Sheath Acceleration (TNSA). At the same time, unwanted electrons and X-rays are segregated from the protons. This part of the setup is located inside the target vessel of the L2A2 laser. A subsequent vacuum flange sealed with a thin kapton window allows for particle passage to external sample irradiation. A combination of passive detector materials and real-time monitors is applied for measurement of the deposited radiation dose. A critical point of this interdisciplinary project is the manipulation of biological samples under well-controlled, sterile conditions. Cell cultures are prepared in sealed flasks with an ultra-thin entrance window and analysed at the nearby Fundación Pública Galega Medicina Xenómica and IDIS. The first trials will be centred at the quantification of DNA double-strand breaks as a function of radiation dose.

19 December 2025 in Physics in Medicine & Biology
Verified
Journal Article
Open access
Lidia Palenciano CastroLidia Palenciano Castro
Lidia Palenciano Castro
MAMarta Anguiano
Marta Anguiano
Objective. This study aims to comprehensively compare the PENHAN and FLUKA Monte Carlo codes for low-energy alpha particle transport and small-scale dosimetry using alpha-emitting radionuclides, and to assess their suitability for such applications. Approach. Two studies were performed through Monte Carlo simulations. First, monoenergetic alpha particles ( 3 − 10 MeV) were distributed in a micrometric water sphere and the dose deposition within it was calculated. Second, a simplified spherical cell model with uniformly distributed alpha-emitting radionuclides was used to compute S -values. PENHAN and FLUKA results were compared, and potential sources of discrepancy between them were analyzed. In addition, both codes were benchmarked against MIRDcell, an analytical tool widely used for dosimetric calculations in Targeted radionuclide therapy. Main results. In the monoenergetic study, the primary source of discrepancy between PENHAN and FLUKA was the stopping powers used for alpha particles. When the same stopping powers were employed, both codes yielded statistically compatible results, except at 3.0 and 3.5 MeV, where FLUKA showed an anomalous behavior. In the cell model, variations were below 3% but not negligible even when using identical stopping powers, suggesting an additional source of discrepancy: differences in the radionuclide emission spectra, particularly in the electron component. In both studies, PENHAN and FLUKA results were overall in good agreement with those from MIRDcell. Significance. This study demonstrates, for the first time, the suitability of PENHAN for low-energy alpha transport and small-scale dosimetry with alpha emitters, provided that accurate stopping powers are employed. It also supports the reliability of FLUKA in these scenarios and shows that both codes yield compatible results when using consistent stopping power datasets and radionuclide emission spectra. This work further highlights the importance of validating Monte Carlo codes in medical physics to ensure the reliability and reproducibility of their results.